Hear from experts in forensic analysis at SCIEX and Phenomenex on the application of LC-MS/MS for tox screening. The complete workflow from sample preparation to reporting will be covered, with an emphasis on both routine compound suites and novel substances. This introductory session is designed for scientists, technicians and lab managers who are new to LC-MS or are considering setting up or expanding compound coverage in a lab.
Stephanie J. Marin, Phenomenex
Aymeric Morla, SCIEX
Aymeric Morla, SCIEX
Stephanie J. Marin is the Clinical and Forensics Global Market Development Manager at Phenomenex. She received her Ph.D. in chemistry from Arizona State University, and has expertise in sample preparation, liquid chromatography and mass spectrometry. She has over 10 years of experience developing and validating clinical methods from her tenure at the ARUP Institute for Clinical and Experimental Pathology. Dr Marin has worked in marketing, product development, and applications development, in addition to customer facing roles in customer and technical support and service and customer education and training. She has also held positions at Hamilton Company, Selerity Technologies and Biotage, and in analytical services for specialty chemicals and polymers at Rohm and Haas (now Dow). She was also a supervisor at an EPA certified laboratory. She is the author of over 30 peer reviewed publications and book chapters and over 100 abstracts presented at national and international meetings.
Aymeric joined the LC/MS support team in 2007. With a background in biochemistry, he developed his expertise in clinical and forensic analysis during the last 16 years. Currently, he is an Applications Lead for EMEAI.